Ferndale Pharma Group, Oculus sales and marketing update

Oculus granted Ferndale's Eloquest Healthcare Inc. subsidiary an exclusive, U.S. license to market its Microcyn-based wound care products, including its Microcyn Negative-Pressure Wound Therapy Solut...